The WACC of Coherus BioSciences Inc (CHRS) is 8.6%.
Range | Selected | |
Cost of equity | 10.90% - 14.70% | 12.80% |
Tax rate | 0.10% - 1.10% | 0.60% |
Cost of debt | 7.00% - 7.70% | 7.35% |
WACC | 7.9% - 9.2% | 8.6% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 1.54 | 1.76 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 10.90% | 14.70% |
Tax rate | 0.10% | 1.10% |
Debt/Equity ratio | 3.38 | 3.38 |
Cost of debt | 7.00% | 7.70% |
After-tax WACC | 7.9% | 9.2% |
Selected WACC | 8.6% | |